Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanda Pharmaceuticals Inc. - Common Stock (NQ:VNDA)

5.080 +0.080 (+1.60%)
Streaming Delayed Price Updated: 9:44 AM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 24,440
Open 5.030
Bid (Size) 5.080 (5,000)
Ask (Size) 5.100 (600)
Prev. Close 5.000
Today's Range 4.960 - 5.100
52wk Range 3.809 - 5.700
Shares Outstanding 55,638,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat ↗
Vanda's tradipitant cut Wegovy-related vomiting by 50% in a new trial, prompting bullish analyst views and price targets. 
Via Benzinga
News headline image
Which stocks are moving on Tuesday? ↗
Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
Via Chartmill

Performance

YTD
+5.4%
+5.4%
1 Month
-9.4%
-9.4%
3 Month
+8.8%
+8.8%
6 Month
+17.3%
+17.3%
1 Year
+0.6%
+0.6%

More News

Read More
News headline image
Top movers in Tuesday's session ↗
Via Chartmill
News headline image
Side Effects From Wegovy? This Vanda Pharmaceuticals' Drug Halves Vomiting In Patients ↗
Via Benzinga
News headline image
Earnings Scheduled For October 29, 2025 ↗
Via Benzinga
Vanda Pharma Stock Rockets 9% After Federal Appeals Court Sets Aside FDA Action: Retail Expects Stock To Cross $5-Mark ↗
Via Stocktwits
News headline image
Earnings Scheduled For July 31, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2025 ↗
Via Benzinga
News headline image
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
News headline image
This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday ↗
Via Benzinga
News headline image
This Trex Company Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday ↗
Via Benzinga
News headline image
VANDA PHARMACEUTICALS INC (NASDAQ:VNDA) Reports Q3 2025 Earnings Miss on Revenue, Beat on EPS ↗
Via Chartmill
Topics Earnings
News headline image
A Glimpse of Vanda Pharma's Earnings Potential ↗
Via Benzinga
News headline image
The Analyst Verdict: Vanda Pharma In The Eyes Of 5 Experts ↗
Via Benzinga
News headline image
Jim Cramer Calls Cameco A Good Company, Recommends Buying This Financial Stock ↗
Via Benzinga
News headline image
AnaptysBio Charts Path To Split Into Two Public Companies By 2026 ↗
Via Benzinga
News headline image
Retail Buzz Builds As Vanda Urges FDA Chief To Revisit Hetlioz Generics Decision — Alleges “Bias Toward Approvals” ↗
Via Stocktwits
Topics Retirement
News headline image
Vanda (VNDA) Q2 Revenue Rises 4% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Earnings Scheduled For February 13, 2025 ↗
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
Forecasting The Future: 5 Analyst Projections For Vanda Pharmaceuticals ↗
Via Benzinga
News headline image
Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist
From AnaptysBio, Inc.
Via GlobeNewswire
News headline image
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate ↗
Via Benzinga
News headline image
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc.
From Glancy Prongay & Murray LLP
Via Business Wire

Frequently Asked Questions

Is Vanda Pharmaceuticals Inc. - Common Stock publicly traded?
Yes, Vanda Pharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does Vanda Pharmaceuticals Inc. - Common Stock trade on?
Vanda Pharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock?
The ticker symbol for Vanda Pharmaceuticals Inc. - Common Stock is VNDA on the Nasdaq Stock Market
What is the current price of Vanda Pharmaceuticals Inc. - Common Stock?
The current price of Vanda Pharmaceuticals Inc. - Common Stock is 5.080
When was Vanda Pharmaceuticals Inc. - Common Stock last traded?
The last trade of Vanda Pharmaceuticals Inc. - Common Stock was at 11/26/25 09:44 AM ET
What is the market capitalization of Vanda Pharmaceuticals Inc. - Common Stock?
The market capitalization of Vanda Pharmaceuticals Inc. - Common Stock is 282.64M
How many shares of Vanda Pharmaceuticals Inc. - Common Stock are outstanding?
Vanda Pharmaceuticals Inc. - Common Stock has 283M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.